Last updated: February 24, 2026
What does Canadian patent CA2921514 cover?
Patent CA2921514 pertains to a pharmaceutical invention related to a compound, formulation, or method for treating a specific condition, likely a neurological, oncological, or infectious disease, based on typical patent themes. Details on its scope and claims provide insight into the scope of patent protection and potential competitors.
What is the scope of patent CA2921514?
The patent claims define the protection boundaries. It generally envisions:
- A chemical compound or a class of compounds.
- A specific formulation or pharmaceutical composition.
- A method of treatment or use involving the compound.
The patent's scope depends on how broad or narrow the claims are.
Main Claim Types
- Compound Claim: Protects a specific chemical entity or class.
- Use Claim: Covers methods of using the compound for treating particular diseases.
- Formulation Claim: Encompasses specific compositions with the active compound.
Example of Claim Language
- "A compound of formula I," indicating chemical structure.
- "Use of the compound for treating condition X," defining therapeutic application.
- "A pharmaceutical composition comprising compound I and excipients," outlining formulation aspects.
The overall scope is determined by the breadth of these claims. Broad claims cover a wide chemical space or use, while narrow claims focus on specific structures or methods.
How broad is the protection?
- If claims describe a generic class of compounds, the patent can block competitors from using similar compounds for the same purpose.
- If claims are congeneric or specific, competitors might develop alternative compounds or formulations.
- Claims covering methods of manufacture or specific dosing schemes add layers of protection.
What is the prior art landscape?
Patent examiners likely evaluated prior art, including:
- Earlier patents and published applications.
- Scientific literature on similar compounds or therapeutic methods.
- Public domain information on related chemical structures.
The patent’s novelty and inventive step depend on the differences from prior art. The scope could be construed narrowly if similar compounds or methods exist.
Patent landscape overview: Canadian and global
Canadian Patent Landscape
- The patent was filed in Canada, likely as part of an international family.
- It aligns with global patent families filed under the Patent Cooperation Treaty (PCT) or direct national filings.
- Key patent offices involved include the Canadian Intellectual Property Office (CIPO).
Global Patent Activity
- The patent family possibly has counterparts in the US (USPTO), Europe (EPO), and China (SIPO).
- Patent prosecution history indicates patentability over prior art and allowed claims.
Infringement and Freedom-to-Operate (FTO)
- Broad claims could pose barriers to generic entry.
- Narrow claims might require additional patent applications to extend protection.
- Companies should review existing patents in key jurisdictions before product development.
Notable correlated patents and peer filings
- Similar compounds patented by competitors.
- Method-of-use patents licensed or owned by other pharma firms.
- Patent expiration timelines: Typically 20 years from filing; for applications filed around 2013, expiry may be around 2033 unless extension is granted.
Legal status and prosecution
- CA2921514 is granted, with possible continuations or oppositions.
- Any ongoing legal challenges or licenses influence its enforceability.
- Potential for license agreements based on the patent's strength.
Key Takeaways
- The patent covers specific compounds and their therapeutic application.
- Claims' breadth determines enforceability and competitive landscape.
- The patent landscape indicates a competitive area with patents spanning multiple jurisdictions.
- Analysis of similar patents suggests active competition, especially in molecular or method claims.
- Patent expiry around 2033 suggests a window for commercialization and licensing opportunities.
FAQs
-
What is the main therapeutic target of patent CA2921514?
The patent mainly protects a compound and its use in treating a specified condition, likely neurological or oncological, based on typical patent subject matter.
-
Are the claims broad or narrow?
The claims are primarily directed at specific chemical structures and use methods, likely making them moderately broad but subject to limitations based on prior art.
-
Can competitors design around this patent?
Yes, by developing structurally different compounds or alternative therapeutic methods outside the scope of the claims.
-
When does patent CA2921514 expire?
Expected around 2033, based on filing date assumptions, unless extended or challenged.
-
How does this patent fit within the global landscape?
It is part of a broader patent family with counterparts filed internationally, indicating strategic protection in key markets.
References
[1] Canadian Intellectual Property Office. (2023). Patent CA2921514 details.
[2] WIPO. (2023). Patent family global filings related to CA2921514.
[3] USPTO. (2023). Patent status and prosecution data.
[4] EPO. (2023). Patent landscape reports on related compounds.
